What Zepbound costs, with dates: LillyDirect self-pay prices by dose for KwikPen and vials, the $25 savings card, employer and Medicaid coverage, and Medicare's $50 GLP-1 Bridge.
Fact-checked against FDA labels and official sources; not yet reviewed by a licensed clinician. This page is education, not medical advice. Talk to your doctor before starting, stopping or changing any treatment.
Key takeaways
- On 2026-10-06, Zepbound self-pay through LillyDirect was $299 a month for 2.5 mg and $399 for 5 mg, in KwikPen or vials.[2]
- Doses of 7.5 mg to 15 mg cost $449 a month with refills within 45 days, or $499 to $699 otherwise.[2]
- With commercial insurance that covers Zepbound, the savings card can lower the cost to $25; the card expires December 31, 2026 and excludes government programs.[1]
- Medicare's GLP-1 Bridge (July 2026 to December 2027) covers the Zepbound KwikPen for weight management with a $50 copay for people who meet its criteria.[6]
- In KFF's 2025 survey, 43% of firms with 5,000 or more workers covered GLP-1s for weight loss.[9]
In short: Checked on October 6, 2026, Zepbound bought directly from Eli Lilly through LillyDirect without insurance costs $299 a month for the 2.5 mg starting dose and $399 for 5 mg, in either the multi-dose KwikPen or single-dose vials. Higher doses (7.5 mg to 15 mg) cost $449 a month when each refill is completed within 45 days, or $499 to $699 a month otherwise. With commercial insurance that covers Zepbound, Lilly’s savings card can bring the cost to as little as $25. Medicare’s temporary GLP-1 Bridge covers the Zepbound KwikPen for weight management with a $50 copay for people who meet its criteria. The White House put the “current price” before these programs at $1,086 a month (November 2025).
This page is about cost only, with every figure dated and linked to the manufacturer’s or the government’s own website. For what Zepbound is, who it is labeled for and its side effects, see the medication page and Zepbound side effects. Nothing here is advice about whether Zepbound is right for you; that is a decision for you and a licensed clinician after an evaluation.
Zepbound cost at a glance (checked October 6, 2026)
- $299per month self-pay for the 2.5 mg starting dose (KwikPen or vial)Eli Lilly
- $449per month self-pay for 7.5 to 15 mg with on-time refills (otherwise $499 to $699)LillyDirect
- $25lowest monthly cost with commercial insurance that covers Zepbound and the savings cardEli Lilly
- $50Medicare GLP-1 Bridge copay (KwikPen, July 2026 to December 2027)CMS
Checked on October 6, 2026
Zepbound prices by dose (checked on October 6, 2026)
| Dose (KwikPen or single-dose vial) | Self-pay with on-time refills (Journey Program) | Regular self-pay price |
|---|---|---|
| 2.5 mg (starting dose only) | $299 per month | $299 per month |
| 5 mg | $399 per month | $399 per month |
| 7.5 mg | $449 per month | $499 per month |
| 10 mg | $449 per month | $699 per month |
| 12.5 mg | $449 per month | $699 per month |
| 15 mg | $449 per month | $699 per month |
| Item | With on-time refills | Regular price |
|---|---|---|
| 2.5 mg | $299 | $299 |
| 5 mg | $399 | $399 |
| 7.5 mg | $449 | $499 |
| 10 mg | $449 | $699 |
| 12.5 mg | $449 | $699 |
| 15 mg | $449 | $699 |
On-time = refill within 45 days of the previous delivery (Zepbound Journey Program). 2.5 mg is a starting dose and not approved as a maintenance dose.
Source: LillyDirect, Zepbound KwikPen and vial self-pay pricing (Eli Lilly) (checked on October 6, 2026)
Lilly notes that 2.5 mg is a starting dose and is not approved as a maintenance dose, so most people’s monthly cost changes as their prescriber increases the dose over the first months. The label describes increases in 2.5 mg steps after at least four weeks on each dose; your prescriber decides your own schedule.
Every way to pay, compared
| How you pay | Form | What you pay (checked October 6, 2026) | Main conditions |
|---|---|---|---|
| Commercial insurance that covers Zepbound + savings card | Single-dose pen, KwikPen or vial | As little as $25 for a 1-, 2- or 3-month fill | Maximum savings $100 to $300 per fill depending on its length, up to $1,300 a year; card expires December 31, 2026; not for anyone in a government-funded health program |
| Commercial insurance that does not cover Zepbound + savings card | Single-dose pen | $499 a month | Card expires December 31, 2026 |
| Self-pay through LillyDirect | KwikPen or single-dose vial | $299 to $449 with on-time refills; up to $699 otherwise | Valid prescription; processed outside insurance |
| Medicare GLP-1 Bridge | KwikPen only | $50 copay | July 1, 2026 to December 31, 2027; weight management; prior authorization and BMI criteria |
| Medicare Part D, sleep apnea use | As covered by the plan | Your plan’s usual cost sharing | For moderate to severe obstructive sleep apnea; not part of the Bridge |
The savings card (the “Zepbound coupon”)
What people search for as a “Zepbound coupon” is Lilly’s savings card. With commercial drug insurance that covers Zepbound, eligible people can pay as little as $25 for a one-, two- or three-month prescription. The card has maximum savings of $100 to $300 per fill depending on its length and a yearly maximum of $1,300, and it expires on December 31, 2026. It cannot be used by anyone enrolled in a state, federal or government-funded program such as Medicare, Medicaid or TRICARE. With commercial insurance that does not cover Zepbound, the card brings the single-dose pen to $499 a month. Lilly can change or end its programs at any time, so check the current terms on its site.
Be careful with websites offering “tirzepatide” for much less. Compounded or “research” tirzepatide is not Zepbound and is not FDA approved, and the FDA determined on December 19, 2024 that the tirzepatide injection shortage was resolved, which limits when pharmacies may compound copies. Our guide to compounded GLP-1s explains the risks.
KwikPen, vial or single-dose pen
- KwikPen (multi-dose, four doses per pen): self-pay through LillyDirect, accepted by insurance, and the only form on Medicare’s GLP-1 Bridge. Pen needles are bought separately. Never share a pen, even if the needle is changed.
- Single-dose vials: self-pay through LillyDirect at the same prices as the KwikPen; you draw each dose with a needle and syringe, which need to be bought separately. The government’s TrumpRx site also lists Zepbound vials and sends orders to LillyDirect.
- Single-dose pens (one dose each, built-in needle): mainly used with insurance; Lilly says this can be the most cost-effective option for people whose commercial insurance covers it and who qualify for the savings card.
Which form you use is a prescription decision. A pharmacist or nurse can show you how to use pens or vials safely.
Insurance coverage
Coverage for weight-management medicines varies by employer and plan. In KFF’s 2025 Employer Health Benefits Survey, 43% of firms with 5,000 or more workers covered GLP-1 medicines when used primarily for weight loss (up from 28% in 2024), compared with 30% of firms with 1,000 to 4,999 workers and 16% of firms with 200 to 999. About a third of the covering firms required a dietitian, case manager, therapist or lifestyle program. Plans that cover Zepbound usually ask the prescriber for prior authorization. Zepbound is also approved for moderate to severe obstructive sleep apnea in adults with obesity, which some plans treat differently from weight management. Step-by-step help is in our GLP-1 insurance coverage guide.
| Item | Value |
|---|---|
| 200 to 999 workers | 16% |
| 1,000 to 4,999 workers | 30% |
| 5,000 or more workers | 43% |
Share of firms offering health benefits that cover GLP-1 agonists when used primarily for weight loss.
Source: KFF 2025 Employer Health Benefits Survey (released October 22, 2025) (checked on October 6, 2026)
Medicare and Medicaid
Medicare is barred by law from covering drugs used for weight loss. To bridge that gap, CMS runs the temporary Medicare GLP-1 Bridge from July 1, 2026 to December 31, 2027. It includes the Zepbound KwikPen (not vials or single-dose pens), Wegovy and Foundayo, with a $50 copay. The prescriber requests prior authorization and attests that the person is 18 or older and meets the criteria: a BMI of 35 or more; or 30 or more with heart failure with preserved ejection fraction, uncontrolled high blood pressure or chronic kidney disease stage 3a or higher; or 27 or more with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease. KFF notes that Bridge copays do not count toward Part D deductibles or the out-of-pocket cap, and Extra Help cannot be applied to them. People using Zepbound for sleep apnea get it through their regular Part D plan.
Medicaid coverage depends on the state: KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026, after California, New Hampshire, Pennsylvania and South Carolina ended coverage. Lilly’s savings card cannot be used with Medicaid.
What a year of Zepbound can cost
Because the price rises with dose, a self-pay year depends on how fast the dose goes up and whether refills are on time. As an illustration only, using the label’s minimum of four weeks per step and LillyDirect’s on-time prices, a person moving through 2.5 mg, 5 mg and then 7.5 mg or higher would pay about $299, then $399, then $449 a month, which works out to roughly $5,100 for the first 12 monthly fills. Your own schedule may be slower, may stop at a lower dose, or may change. Pen needles or syringes are extra.
| Item | Value |
|---|---|
| Month 1 (2.5 mg) | $299 |
| Month 2 (5 mg) | $399 |
| Months 3 to 12 (7.5 mg or higher), each | $449 |
Illustration, not a prediction or a dosing plan: $299 + $399 + 10 x $449 = $5,188. Your prescriber sets your doses.
Source: Prices: LillyDirect (Eli Lilly); dose steps: Zepbound prescribing information (checked on October 6, 2026)
Ways to lower the cost, and what to avoid
- Ask your plan first. Is Zepbound on the formulary, for which uses, and what does prior authorization require?
- Compare the card with self-pay. With coverage, the savings card is usually lowest; without it, compare LillyDirect self-pay with the card’s single-dose pen price.
- Refill on time. On higher doses, a refill more than 45 days after the last delivery raises the self-pay price from $449 to $499-$699.
- Check the Medicare Bridge if you have Part D and meet its criteria; ask your prescriber to submit the prior authorization.
- Use HSA or FSA funds where allowed. LillyDirect lists Zepbound as HSA/FSA eligible, with eligibility varying by plan; the IRS allows prescribed medicines and weight-loss treatment for a diagnosed disease such as obesity as medical expenses. Confirm with your plan administrator.
- Avoid unapproved sellers. Buy only with a prescription from a state-licensed pharmacy or the manufacturer’s pharmacy.
Compare with other medicines: Wegovy cost, Mounjaro cost (the same molecule approved for type 2 diabetes), Wegovy vs Zepbound and the GLP-1 cost comparison tool. More on the costs hub and the insurance hub. If cost makes you consider stopping, plan it with your prescriber; see life after a GLP-1.
Prices, with the date we checked them
What you pay for Zepbound depends on the dose, the form (KwikPen, vial or single-dose pen), whether refills are on time, whether you use commercial insurance, the savings card, Medicare's GLP-1 Bridge or self-pay, and your plan's prior-authorization rules. Self-pay fills are processed outside insurance. Prices checked on 2026-10-06.
| Option | Price | Amount | Basis | Checked on |
|---|---|---|---|---|
| Zepbound (tirzepatide): uses, side effects, cost and FDA status | Self-pay / cash | 299 USD | per month, 2.5 mg KwikPen or vials (LillyDirect and other pharmacies) | October 6, 2026 |
| Zepbound (tirzepatide): uses, side effects, cost and FDA status | Self-pay / cash | 399 USD | per month, 5 mg KwikPen | October 6, 2026 |
| Zepbound (tirzepatide): uses, side effects, cost and FDA status | Self-pay / cash | 449 USD | per month, 7.5 mg to 15 mg KwikPen, refill within 45 days (regular $499 for 7.5 mg, $699 for 10 to 15 mg) | October 6, 2026 |
| Zepbound (tirzepatide): uses, side effects, cost and FDA status | With savings program | 25 USD | per 1- to 3-month fill with commercial coverage (card expires 2026-12-31) | October 6, 2026 |
Prices change often and depend on pharmacy, plan and location. Insurance can change what you pay. Every price shows the date we checked it.
Related guides
Does Insurance Cover GLP-1s for Weight Loss? (checked quarterly)Does insurance cover GLP-1s for weight loss? Employer data, Medicare rules and the $50 GLP-1 Bridge,…
Wegovy Cost, Coupons and Savings Programs (prices checked monthly)What Wegovy costs, with dates: list price, NovoCare self-pay prices for pens and pills, the $25…
Weight-Loss Costs: medications, programs and procedures, with datesWhat weight-loss treatments cost, with dates: GLP-1 self-pay prices, programs, procedures, Medicare and insurance, HSA and…
Mounjaro Cost: self-pay price, savings card and Medicare (prices checked monthly)What Mounjaro costs, with dates: $499 LillyDirect self-pay at every strength, the $25 savings card and…Latest research
How to Read a Weight-Loss Study Headline in 5 StepsFive questions to ask before believing a weight-loss headline: who was studied, how many, how long,…
What’s Coming in 2027: Weight-Loss Treatments Awaiting FDA DecisionsWeight-loss treatments awaiting FDA decisions in 2027: CagriSema, retatrutide, survodutide, MariTide and more, with filing dates,…
Fake and Counterfeit Weight-Loss Drugs: How to Spot ThemCounterfeit Ozempic has reached U.S. pharmacies three times. The FDA alerts, what online test buys found,…Questions to ask a professional
- Does my plan cover Zepbound, for weight management or sleep apnea, and what does prior authorization require?
- Would the savings card or LillyDirect self-pay cost me less this year?
- KwikPen, vial or single-dose pen: which form fits my prescription and budget?
- Am I eligible for the Medicare GLP-1 Bridge, and can you submit the prior authorization?
- What dose schedule should I budget for over the first year?
- If cost forces me to stop, how should we plan it?
Frequently asked questions
How much does Zepbound cost without insurance?
On 2026-10-06, LillyDirect self-pay was $299 a month for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg to 15 mg with refills within 45 days ($499 for 7.5 mg and $699 for 10 to 15 mg otherwise), for the KwikPen or single-dose vials.
Is there a Zepbound coupon?
Lilly's savings card lets people with commercial insurance that covers Zepbound pay as little as $25 for a 1- to 3-month fill, up to $1,300 in savings a year; without coverage it brings the single-dose pen to $499 a month. It expires December 31, 2026 and cannot be used with government insurance.
Are Zepbound vials cheaper than pens?
Through LillyDirect, vials and the KwikPen have the same self-pay prices by dose ($299 to $449 with on-time refills). Vials need syringes and needles; KwikPens need pen needles.
Does Medicare cover Zepbound?
For weight management, the temporary Medicare GLP-1 Bridge (July 1, 2026 to December 31, 2027) covers the Zepbound KwikPen with a $50 copay for people who meet its BMI and condition criteria and get prior authorization. For obstructive sleep apnea, coverage goes through the regular Part D plan.
Does Medicaid cover Zepbound?
It depends on the state. KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026.
Why does the price go up after a few months?
Self-pay prices rise with the dose, and the label describes dose increases every four weeks or more. The 2.5 mg starting dose is not approved as a maintenance dose.
What happens if I refill late?
For 7.5 mg to 15 mg, the $449 Journey Program price requires completing each refill within 45 days of the previous delivery; otherwise regular prices apply ($499 for 7.5 mg, $699 for 10 to 15 mg).
Can I use my HSA or FSA for Zepbound?
LillyDirect lists Zepbound as HSA/FSA eligible, with eligibility varying by plan. The IRS treats prescribed medicines and weight-loss treatment for a diagnosed disease such as obesity as medical expenses. Check with your plan administrator.
Is compounded tirzepatide a cheaper alternative?
Compounded tirzepatide is not FDA approved and is not Zepbound. The FDA has raised concerns about unapproved GLP-1 products; see our compounded GLP-1 guide before considering any.
References
- Zepbound coverage and savings. Eli Lilly and Company. (accessed October 6, 2026) Other
- Zepbound at LillyDirect: self-pay prices. Eli Lilly and Company. (accessed October 7, 2026) Other
- ZEPBOUND (tirzepatide) injection: prescribing information. Eli Lilly and Company, via DailyMed, 2026. (accessed October 7, 2026) Drug label
- Fact Sheet: President Donald J. Trump Announces Major Developments in Bringing Most-Favored-Nation Pricing to American Patients. The White House, 2025. (accessed October 6, 2026) Government page
- Zepbound vial on TrumpRx. TrumpRx.gov (U.S. government). (accessed October 6, 2026) Government page
- Medicare GLP-1 Bridge: information for providers. Centers for Medicare and Medicaid Services. (accessed October 7, 2026) Government page
- What Medicare’s Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries. KFF, 2026. (accessed October 6, 2026) Other
- CMS Extends Medicare’s Short-Term Bridge Program for GLP-1 Obesity Drug Coverage. KFF. (accessed October 6, 2026) Other
- 2025 Employer Health Benefits Survey. KFF, 2025. (accessed October 6, 2026) Other
- Medicaid Coverage of and Spending on GLP-1s. KFF, 2026. (accessed October 6, 2026) Other
- Publication 502 (2025), Medical and Dental Expenses. Internal Revenue Service, 2025. (accessed October 6, 2026) Government page
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (content current as of 2026-04-01). U.S. Food and Drug Administration. (accessed October 6, 2026) Government page
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, 2026. (accessed October 7, 2026) Government page
Facts checked on October 6, 2026
Educational information, not medical advice. Talk with a qualified healthcare professional about your own situation. In an emergency call 911.